Chardham Yatra to begin from today with strict guidelines; check details here

-

The Chardham Yatra in Uttarakhand is all set to start from today, 18 September. The decision comes after the Uttarakhand High Court had lifted the ban on the yatra on 16 September. The court had stated that the yatra would follow COVID-19 protocols on its resumption.

According to The Times of India, Uttarakhand Chief Minister Pushkar Singh Dhami said that his government would ensure that “everyone follows the COVID protocols and directives” which have been issued by the high court.

Here’s all you need to know about the new Standard Operating Procedures (SOPs) for the Chardham Yatra:

Only people who have been fully vaccinated, or carry a COVID-19 negative report, are allowed. Pilgrims will have to carry a vaccination certificate proving they have been administered both doses of the COVID-19 vaccine at least 15 days back. If the pilgrim has not been fully vaccinated, a negative COVID-19 test report not older than 72 hours is necessary.

For devotees coming in from Maharashtra, Kerala and Andhra Pradesh, entry would be allowed only if the pilgrims are fullly vaccinated and have a COVID-19 negative report.

A limit has been imposed on the number of travellers permitted daily. A cap of not more than 1,000 devotees for Badrinath, 800 for Kedarnath, 600 people for Gangotri, and 400 for Yamunotri has been fixed.

No person will be permitted to bathe in the river or springs in and around the temples.

Only three persons will be allowed at a time inside the sanctum sanctorum of the shrines. Social distancing measures would be maintained among the devotees entering or leaving the temples.

Devotees coming from other states need to register themselves at the Smart City portal available at https://ift.tt/31RZQAk for obtaining an e-pass for the Chardham Yatra. The pass would be valid for two days.

The Chardham Yatra was suspended for a period of three months by the high court due to inadequate preparations to control coronavirus infections and shortage of medical facilities.



from Firstpost India Latest News https://ift.tt/3kk1OUY
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more